Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Robert P. Doornbos
Observed names:
Doornbos, Robert P.,
R DOORNBOS,
R. Doornbos,
R. P. DOORNBOS,
R.P Doornbos,
R.P. Doornbos,
Robert Doornbos
show all 7
Institution:
Merus (Netherlands)
Observed institutions:
Leiden University,
Netherlands Organisation for Applied Scientific Research,
Utrecht University,
Radboud University Medical Center,
Merus (Netherlands)
OpenAlex ID:
A5081594407
Protein Kinase Cζ Is a Negative Regulator of Protein Kinase B Activity
1999
·
Robert P. Doornbos
, Marga Theelen
, et al.
·
Journal of Biological Chemistry
·
139
PDF
MCLA-117, a CLEC12AxCD3 bispecific antibody targeting a leukaemic stem cell antigen, induces T cell-mediated AML blast lysis
2019
·
Pieter Fokko van Loo
, Basav N. Hangalapura
, et al.
·
Expert Opinion on Biological Therapy
·
66
PDF
Melanocortin receptors mediate α-MSH-induced stimulation of neurite outgrowth in neuro 2A cells
1996
·
R.A.H. Adan
, M. van der Kraan
, et al.
·
Molecular Brain Research
·
51
The influence of microbial metabolites on human intestinal epithelial cells and macrophages in vitro
2005
·
Marleen H.M.C. Nuenen
, Rianne A.F. Ligt
, et al.
·
FEMS Immunology & Medical Microbiology
·
49
PDF
Inhibitory effects of the β2‐adrenergic receptor agonist zilpaterol on the LPS‐induced production of TNF‐α in vitro and in vivo
2005
·
K. C. M. VERHOECKX
, R. P. DOORNBOS
, et al.
·
Journal of Veterinary Pharmacology and Therapeutics
·
44
PDF
Beta-adrenergic receptor agonists induce the release of granulocyte chemotactic protein-2, oncostatin M, and vascular endothelial growth factor from macrophages
2005
·
Kitty C.M. Verhoeckx
, Robert P. Doornbos
, et al.
·
International Immunopharmacology
·
41
Translational PK-PD modeling analysis of MCLA-128, a HER2/HER3 bispecific monoclonal antibody, to predict clinical efficacious exposure and dose
2018
·
Aurelia H. M. de Vries Schultink
, Robert P. Doornbos
, et al.
·
Investigational New Drugs
·
36
PDF
Preclinical Evaluation of MCLA117, a CLEC12AxCD3 Bispecific Antibody Efficiently Targeting a Novel Leukemic Stem Cell Associated Antigen in AML
2015
·
Pieter Fokko Van Loo
, Robert Doornbos
, et al.
·
Blood
·
35
Alpha-MSH stimulates neurite outgrowth of neonatal rat corticospinal neurons in vitro
1996
·
E.A.J. Joosten
, S. Verhaagh
, et al.
·
Brain Research
·
32
Do aberrant crypt foci have predictive value for the occurrence of colorectal tumours? Potential of gene expression profiling in tumours
2004
·
M.V.W Wijnands
, M.J van Erk
, et al.
·
Food and Chemical Toxicology
·
31
In Search of Secreted Protein Biomarkers for the Anti-inflammatory Effect of β2-Adrenergic Receptor Agonists: Application of DIGE Technology in Combination with Multivariate and Univariate Data Analysis Tools
2005
·
Kitty C. M. Verhoeckx
, Marco Gaspari
, et al.
·
Journal of Proteome Research
·
30
PA401, a novel CXCL8-based biologic therapeutic with increased glycosaminoglycan binding, reduces bronchoalveolar lavage neutrophils and systemic inflammatory markers in a murine model of LPS-induced lung inflammation
2015
·
Tiziana Adage
, Francesca del Bene
, et al.
·
Cytokine
·
23
The Göttingen minipig®as an alternative non-rodent species for immunogenicity testing: A demonstrator study using the IL-1 receptor antagonist anakinra
2012
·
Geertje J. D. van Mierlo
, Nicole H. P. Cnubben
, et al.
·
Journal of Immunotoxicology
·
21
PDF
Population Pharmacokinetics of MCLA-128, a HER2/HER3 Bispecific Monoclonal Antibody, in Patients with Solid Tumors
2020
·
Aurelia H. M. de Vries Schultink
, Kees Bol
, et al.
·
Clinical Pharmacokinetics
·
20
Abstract CT050: A Phase I/II Study of MCLA-128, a full length IgG1 Bispecific Antibody Targeting HER2 and HER3, in Patients with Solid Tumors
2016
·
Emiliano Calvo
, Maria Alsina
, et al.
·
Cancer Research
·
15
Integration of efficacy, pharmacokinetic and safety assessment of interleukin-1 receptor antagonist in a preclinical model of arthritis
2011
·
Anne-Marie Zuurmond
, Angela Koudijs
, et al.
·
Regulatory Toxicology and Pharmacology
·
14
Abstract LB-261: Mechanism of action of MCLA-128, a humanized bispecific IgG1 antibody targeting the HER2:HER3 heterodimer
2015
·
Cecile Geuijen
, Eric Rovers
, et al.
·
Cancer Research
·
10
Abstract 32: Preclinical evaluation of MCLA-158: A bispecific antibody targeting LGR5 and EGFR using patient-derived colon carcinoma organoids
2017
·
Rob Roovers
, Bram Herpers
, et al.
·
Cancer Research
·
7
Abstract 33: The binding mode of the bispecific anti-HER2xHER3 antibody MCLA-128 is responsible for its potent inhibition of HRG-driven tumorigenesis
2017
·
David Maussang-Detaille
, Camilla de Nardis
, et al.
·
Cancer Research
·
3
PA401, A Novel Decoy CXCL8- Based Biologic Therapeutic Reduces Lung Inflammation Induced By LPS As Well As Plasma Inflammatory Markers In Mice
2012
·
Tiziana Adage
, Francesca Del Bene
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
1
PK/PD profiles of the CXCL8 decoy protein PA401 after intravenous and intratracheal administration in saline and LPS exposed mice
2012
·
Tiziana Adage
, Angelika Falsone
, et al.
·
European Respiratory Journal
Melanocortin receptors and nerve regeneration
1995
·
M VANDERKRAAN
, R ADAN
, et al.
·
Pharmacological Research
Show more works
View as search
Works count:
23
Citation count:
668
H-index:
15
I10-index:
17
Year
Topic
Type